CDH1 and hepatocellular carcinoma: Although the loss of E-CAD has been correlated with poor prognosis in HCC [54,55], paradoxically, the E-CAD expression is increased in around 40% of HCCs, suggesting a requirement for E-CAD at certain stages of the tumorigenesis [56,57].